ArticleSleep advances : a journal of the Sleep Research Society2026
Hidden oral inflammation and biomarker misclassification in obstructive sleep apnea trials.
Article in Sleep advances : a journal of the Sleep Research Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Inflammatory biomarkers are used as surrogate endpoints in obstructive sleep apnea trials, assuming the measured signal originates from the airway or systemic response to intermittent hypoxia. Periodontitis-a common, extrapulmonary inflammatory reservoir-elevates systemic active matrix metalloproteinase-8 independently of obstructive sleep apnea. This Perspective examines whether unmeasured oral inflammation confounds biomarker attribution in obstructive sleep apnea trials. Epidemiological and interventional evidence indicates that periodontitis is highly prevalent, is more common in individuals with obstructive sleep apnea, and substantially elevates circulating active matrix metalloproteinase-8. Moreover, non-surgical periodontal therapy reduces this signal to a degree comparable to early Continuous Positive Airway Pressure (CPAP) effects. In published CPAP trials that reported inflammatory or cardiovascular outcomes, periodontal status has not been reported or incorporated into primary analyses. We propose a heuristic conceptual model: measured circulating active matrix metalloproteinase-8 = obstructive sleep apnea-related component + periodontal-derived component + measurement noise. Without adjustment for periodontal status, observed changes cannot be uniquely attributed to obstructive sleep apnea treatment. The ORBIT heuristic framework (Oral Reservoir Bias Inflammatory Trial) is introduced as a conceptual prompt for reporting oral inflammatory burden. Inflammatory biomarker responses in obstructive sleep apnea trials are consistent with a composite signal that includes an unmeasured oral component. A testable prediction is that adjusting for periodontal status would reduce between-trial heterogeneity of matrix metalloproteinase-8effect estimates without altering within-subject respiratory outcomes. Prospective validation is warranted. The framework extends beyond active matrix metalloproteinase-8 to any circulating inflammatory marker influenced by extra-target inflammatory reservoirs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.